Regulation 2006/1920 - European Monitoring Centre for Drugs and Drug Addiction (recast) - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (recast)| Legal instrument | Regulation |
|---|---|
| Number legal act | Regulation 2006/1920 |
| Original proposal | COM(2005)399  |
| CELEX number i | 32006R1920 |
| Document | 12-12-2006 |
|---|---|
| Publication in Official Journal | 27-12-2006; Special edition in Bulgarian: Chapter 01 Volume 007,OJ L 376, 27.12.2006,Special edition in Romanian: Chapter 01 Volume 007 |
| Effect | 16-01-2007; Entry into force Date pub. + 20 See Art 25 |
| End of validity | 01-07-2024; Repealed by 32023R1322 |
27.12.2006 |
EN |
Official Journal of the European Union |
L 376/1 |
REGULATION (EC) No 1920/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 12 December 2006
on the European Monitoring Centre for Drugs and Drug Addiction (recast)
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular Article 152 thereof,
Having regard to the proposal from the Commission,
Having regard to the opinion of the European Economic and Social Committee (1),
After consulting the Committee of the Regions,
Acting in accordance with the procedure laid down in Article 251 of the Treaty (2),
Whereas:
(1) |
At its meeting in Luxembourg on 28 and 29 June 1991, the European Council, approved the setting-up of a European Drugs Monitoring Centre. Such a body, named the European Centre for Drugs and Drug Addiction (‘the Centre’), was established by Council Regulation (EEC) No 302/93 of 8 February 1993 (3), which has been substantially amended several times (4). Since further amendments are to be made, it should, in the interests of clarity, be recast. |
(2) |
Factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences is required at Community level to help provide the Community and the Member States with an overall view and thus give them added value when, in their respective areas of competence, they take measures or decide on action to combat drugs. |
(3) |
The drug phenomenon comprises many complex and closely interwoven aspects which cannot easily be dissociated. Therefore, the Centre should be entrusted with the task of furnishing general information which will help to provide the Community and its Member States with an overall view of the drug and drug addiction phenomenon. This task should not prejudice the allocation of powers between the Community and its Member States with regard to legislative provisions concerning drug supply and demand. |
(4) |
By means of Decision No 2367/2002/EC of 16 December 2002 (5), the European Parliament and the Council established the Community statistical programme for the period from 2003 to 2007, which includes the Community's actions on statistics in the field of health and safety. |
(5) |
Council Decision 2005/387/JHA of 10 May 2005 on information exchange, risk-assessment and control of new psychoactive substances (6) sets out the role of the Centre and its Scientific Committee in the rapid information system and in the assessment of the risks of new substances. |
(6) |
Account should be taken of new methods of use, especially poly-drug use, where illicit drugs are taken in combination with licit drugs or medication. |
(7) |
It should be one of the Centre's tasks to provide information on best practices and guidelines in the Member States and to facilitate the exchange of such practices among them. |
(8) |
The Council Resolution of 10 December 2001 on the implementation of the five key epidemiological indicators on drugs urges Member States to ensure, making use of national focal points, that comparable information on those indicators is available. The implementation by Member States of those indicators is a precondition for the Centre to perform its tasks as set out in this Regulation. |
(9) |
It is desirable for the Commission to be able to entrust the Centre directly with the implementation of Community structural assistance projects relating to drug information systems in third countries such as the candidate countries or the countries of the western Balkans which have been authorised by the European Council to participate in Community programmes and agencies. |
(10) |
The way in which the Centre is organised and its... |
More
This text has been adopted from EUR-Lex.
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the summary of legislation, de geconsolideerde versie, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand, the related cases of the European Court of Justice and finally consultations relevant to the dossier at hand.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.